Profusa adopts nvidia-powered technology to build ai-driven insight portal for continuous biomarker monitoring

Company expects early 2026 rollout in eea; physician portal combines lumee™ oxygen monitoring with nvidia nemo to deliver ai-driven clinical workflows

PFSA Ratings Summary

PFSA Quant Ranking